A detailed history of Edmond De Rothschild Holding S.A. transactions in Pfizer Inc stock. As of the latest transaction made, Edmond De Rothschild Holding S.A. holds 2,269,731 shares of PFE stock, worth $60.7 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
2,269,731
Previous 2,774,350 18.19%
Holding current value
$60.7 Million
Previous $77.6 Million 15.38%
% of portfolio
1.09%
Previous 1.36%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$27.7 - $31.39 $14 Million - $15.8 Million
-504,619 Reduced 18.19%
2,269,731 $65.7 Million
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $2.14 Million - $2.51 Million
84,734 Added 3.15%
2,774,350 $77.6 Million
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $2.01 Million - $2.31 Million
77,752 Added 2.98%
2,689,616 $74.6 Million
Q4 2023

Feb 12, 2024

BUY
$26.13 - $33.94 $8.13 Million - $10.6 Million
310,962 Added 13.51%
2,611,864 $75.2 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $16.6 Million - $19.3 Million
515,772 Added 28.89%
2,300,902 $76.3 Million
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $14.9 Million - $17.3 Million
413,645 Added 30.16%
1,785,130 $65.5 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $15.2 Million - $19.8 Million
385,390 Added 39.08%
1,371,485 $56 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $68,303 - $89,162
-1,636 Reduced 0.17%
986,095 $50.5 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $600,343 - $732,868
13,719 Added 1.41%
987,731 $43.2 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $743,502 - $881,561
15,979 Added 1.67%
974,012 $51.1 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $46,344 - $57,426
-1,013 Reduced 0.11%
958,033 $49.6 Million
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $10.7 Million - $15.9 Million
-259,064 Reduced 21.27%
959,046 $56.6 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $715,409 - $919,005
18,227 Added 1.52%
1,218,110 $52.4 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $8.19 Million - $9.28 Million
228,170 Added 23.48%
1,199,883 $47 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $6.51 Million - $7.34 Million
194,392 Added 25.01%
971,713 $35.2 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $1.37 Million - $1.75 Million
-41,042 Reduced 5.02%
777,321 $28.6 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $39,878 - $46,786
1,256 Added 0.15%
818,363 $30 Million
Q2 2020

Aug 07, 2020

SELL
$30.12 - $36.54 $2.56 Million - $3.1 Million
-84,844 Reduced 9.41%
817,107 $26.7 Million
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $5.14 Million - $7.34 Million
-190,103 Reduced 17.41%
901,951 $29.4 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $2.13 Million - $2.41 Million
-64,620 Reduced 5.59%
1,092,054 $42.8 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $2.53 Million - $3.28 Million
-77,957 Reduced 6.31%
1,156,674 $41.6 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $2.67 Million - $3 Million
-72,299 Reduced 5.53%
1,234,631 $53.5 Million
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $2.82 Million - $3.09 Million
-75,110 Reduced 5.43%
1,306,930 $55.5 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $15.4 Million - $17.6 Million
-401,039 Reduced 22.49%
1,382,040 $60.3 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $8.39 Million - $10.2 Million
-243,408 Reduced 12.01%
1,783,079 $78.6 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $2.18 Million - $2.32 Million
-66,117 Reduced 3.16%
2,026,487 $73.5 Million
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $1.45 Million - $1.68 Million
45,365 Added 2.22%
2,092,604 $74.3 Million
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $21.1 Million - $22.4 Million
-633,501 Reduced 23.63%
2,047,239 $74.2 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $83.1 Million - $91.5 Million
2,680,740
2,680,740 $95.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Edmond De Rothschild Holding S.A. Portfolio

Follow Edmond De Rothschild Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.